您的位置: 首页 > 农业专利 > 详情页

PHARMACEUTICAL FORMULATIONS FOR SUSTAINED RELEASE OF SEBACOYL DINALBUPHINE ESTER
专利权人:
LUMOSA THERAPEUTICS CO., LTD.;SHANGHAI LUMOSA THERAPEUTICS CO., LTD.
发明人:
Chan-Jung LI,David Chih-Kuang CHOU,Jin-Ding HUANG,Shin-Jr TSAI,Shu-Wen KUO,Yu-En TIEN
申请号:
US16793465
公开号:
US20200179373A1
申请日:
2020.02.18
申请国别(地区):
US
年份:
2020
代理人:
摘要:
The present invention relates to injectable, extended-release, pharmaceutical formulations comprising a nalbuphine ester prodrug homogenously dissolved in a solution comprising a pharmaceutically acceptable oil and an oil-miscible retaining solvent, as well as manufacturing processes and medical uses of the formulations. The invention further provides methods for adjusting the duration of action of the formulations by varying the ratio of the pharmaceutically acceptable oil and the oil-miscible retaining solvent.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充